Zdrowie i gospodarka · 10.03.1994
Prospective Grant of Exclusive Patent License
The National Institutes of Health (NIH) is contemplating the grant of an exclusive license to Samuelsson & Wadstein Medicina AB for the inventions embodied in U.S. Patent 4,371,673, entitled 'Water Soluble Forms of Retinoids', for skin care products and wound healing applications.